4F2C13
4F2C13
规格:
货期:
编号:TS212843
品牌:Testobio
| 产品名称： | 4F2C13 |
|---|---|
| 商品货号： | TS212843 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | Leukemia |
| Applications： | This line is derived from the same fusion used to produce ATCC HB-2 and ATCC HB-21. The antibody reacts with peripheral blood monocytes and to a lesser extent peripheral blood T cells. The antibody fixes complement and binds to Protein A. Tested and found negative for ectromelia virus (mousepox). |
| Derivation： | Spleen cells were fused with P3X63Ag8 myeloma cells. This line is derived from the same fusion used to produce ATCC HB-2 and ATCC HB-21. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against human monocyte |
| Cellular Products： | immunoglobulin; monoclonal antibody; against human monocyte |
| Tumorigenic： | Yes |
| Effects： | Yes, in pristane primed BALB/c mice |
| Comments： | Animals were immunized with HSB-2 cells (ATCC CCL-120.1, an acute lymphocytic T leukemia cell line). Spleen cells were fused with P3X63Ag8 myeloma cells. This line is derived from the same fusion used to produce ATCC HB-2 and ATCC HB-21. The antibody reacts with peripheral blood monocytes and to a lesser extent peripheral blood T cells. The antibody fixes complement and binds to Protein A. Tested and found negative for ectromelia virus (mousepox). |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated Dulbeccos Modified Eagles Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Cryopreservation： | Freeze medium: complete growth medium, 95%; DMSO, 5% |
| Culture Conditions： | Temperature: 37.0°C Atmosphere: air, 95%; carbon dioxide (CO2), 5% |
| Isotype： | IgG2a; kappa light chain |
| Name of Depositor： | A Fauci, BF Haynes |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| References： | Eisenbarth GS, et al. Production of monoclonal antibodies reacting with peripheral blood mononuclear cell surface differentiation antigens. J. Immunol. 124: 1237-1244, 1980. PubMed: 6153676 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
4F2C13
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | 4F2C13 |
|---|---|
| 商品货号： | TS212843 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | Leukemia |
| Applications： | This line is derived from the same fusion used to produce ATCC HB-2 and ATCC HB-21. The antibody reacts with peripheral blood monocytes and to a lesser extent peripheral blood T cells. The antibody fixes complement and binds to Protein A. Tested and found negative for ectromelia virus (mousepox). |
| Derivation： | Spleen cells were fused with P3X63Ag8 myeloma cells. This line is derived from the same fusion used to produce ATCC HB-2 and ATCC HB-21. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against human monocyte |
| Cellular Products： | immunoglobulin; monoclonal antibody; against human monocyte |
| Tumorigenic： | Yes |
| Effects： | Yes, in pristane primed BALB/c mice |
| Comments： | Animals were immunized with HSB-2 cells (ATCC CCL-120.1, an acute lymphocytic T leukemia cell line). Spleen cells were fused with P3X63Ag8 myeloma cells. This line is derived from the same fusion used to produce ATCC HB-2 and ATCC HB-21. The antibody reacts with peripheral blood monocytes and to a lesser extent peripheral blood T cells. The antibody fixes complement and binds to Protein A. Tested and found negative for ectromelia virus (mousepox). |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated Dulbeccos Modified Eagles Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Cryopreservation： | Freeze medium: complete growth medium, 95%; DMSO, 5% |
| Culture Conditions： | Temperature: 37.0°C Atmosphere: air, 95%; carbon dioxide (CO2), 5% |
| Isotype： | IgG2a; kappa light chain |
| Name of Depositor： | A Fauci, BF Haynes |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| References： | Eisenbarth GS, et al. Production of monoclonal antibodies reacting with peripheral blood mononuclear cell surface differentiation antigens. J. Immunol. 124: 1237-1244, 1980. PubMed: 6153676 |
